Absci (ABSI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
The virtual annual meeting was called to order, with board members and executives introduced and present.
The meeting agenda included formal business, voting on director elections, and ratification of the accounting firm.
Board and executive committee updates
Board members present included Frans van Houten, Professor Sir Mene Pangalos, Karen McGinnis, Dan Rabinovitsj, Mary Szela, and Joseph Sirosh.
Shareholder proposals
Two nominees, Professor Sir Menelas Pangalos and Daniel Rabinovitsj, were nominated for Class II director positions for three-year terms.
No stockholder nominations for directors were received.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Absci
- AI-driven ABS-201 nears pivotal Phase 2 readouts for hair loss and endometriosis in major markets.ABSI
Goldman Sachs 47th Annual Global Healthcare Conference 202619 Jun 2026 - AI-powered platform advances ABS-201 in hair loss and endometriosis, with major data ahead.ABSI
Jefferies Global Healthcare Conference 20264 Jun 2026 - ABS-201 advances with key data ahead, cash runway into 2028, and pipeline expansion.ABSI
Q1 202611 May 2026 - AI-driven platform accelerates antibody drug discovery, advancing ABS-201 for AGA and endometriosis.ABSI
Corporate presentation7 May 2026 - Annual meeting to elect directors, ratify auditor, and highlight clinical and AI platform progress.ABSI
Proxy filing23 Apr 2026 - Vote on director elections and auditor ratification at the June 2026 virtual annual meeting.ABSI
Proxy filing23 Apr 2026 - ABS-201 targets AGA and endometriosis with AI-designed antibodies, aiming for major clinical milestones.ABSI
25th Annual Needham Virtual Healthcare Conference16 Apr 2026 - ABS-201 clinical progress and strong cash reserves support major milestones despite higher net loss.ABSI
Q4 202524 Mar 2026 - AI-driven pipeline targets AGA and endometriosis, with pivotal data and commercialization plans ahead.ABSI
Leerink Global Healthcare Conference 20269 Mar 2026